Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alpheus, Atom, Biosplice, Cybin, Equillium, Immix, Immunitybio, Inventprise, Janssen, Longeveron, Nanology, Oncosec, Que, Redx, Resolve, Stellas, TME, Unicycive.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allysta, Ambrx, Atyr, Beckley, Chemomab, Clearside, Dynamicure, Enanta, Flugen, Inflarx, Meissa, Merrimack, Revolo Trevena.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acelyrin, Achieve, Adaptimmune, Alnylam, Amgen, Arrowhead, Astrazeneca, Bicycle, Biosenic, Bridge, Cincor, Dermavant, Galecto, Horizon, Idorsia, Inmagene, Intercept, Ionis, ISA, Janssen, Medincell, Milestone, Mirum, NLS, Novartis, Novavax, Nycode, Onquality, Poxel, Rhythm, Sirnaomics, Vaxxas, Xencor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Brainstorm, Ferring, GSK, Rallybio, Regeneron, Scisparc, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascentage, Bioatla, Biomind, Biontech, Laurent, NGM, Pfizer, Rain, Redhill, Vicore.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abeona, Actinium, Aelix, Albireo, Apeiron, Aramis, Arbutus, Ardelyx, Atea, Biontech, Biophytis, Blaze, Chinook, Clairvoyant, Compass, Daewoong, Emergent, G1, GSK, Inozyme, Lianbio, Madrigal, Neurocrine, Neurotech, Ose, Pfizer, Regenxbio, Regulus, Renovion, Rhythm, Rigel, Sagimet, Sonnet, Surface Oncology, Syndax, Theriva, Transgene, Uniqure, Vectivbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akston, Biothera, Cingulate, Denali, Dragonfly, Ensysce, Harmony, Hoth, Merck, Monte Rosa, Orum, Pfizer, Pieris, Promore, Receptor, Remegen, Stealth, Teon, Unity, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, Actinium, Akeso, BMS, Cerecin, Disc, Essa, First Wave, Innocare, Innovent, Instil, Kalvista, Merck & Co., Nicox, Pharmazz, Scancell, Senhwa, United Therapeutics, Vaccitech, Verge.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edgewise, Morphosys, Nuvalent, Quantum Genomics, Sanofi, Sciwind, Urovant Sciences, Vyluma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aphaia, Astrazeneca, Biomea Fusion, Bristol Myers Squibb, Galera, Genentech, GSK, Homology Medicines, Hutchmed, Intrommune, Kintor, Melt, Mustang, Muvon, Neurocrine, Nykode, Omega, Puma, Q32, Roche.